MENU
INSM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Insmed (INSM) Ownership - Who owns Insmed?

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
700 US Highway 202/206
Phone
+1 908 977-9900
Employees
912
Web
https://www.insmed.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
42.36B
P/E Ratio
N/A
Total Cash
1.68B
Projected Growth
N/A
Total Debt
576.28M
Revenue
447.02M
Risk (Beta)
1.70
Dividend Yield
N/A
Total Cash/Share
7.88
Total Debt/Equity
15.03
Revenue/Share
2.35 USD as % of share price

Fundamentals

INSM
Capitalization
42.4B
P/E Ratio
N/A
Risk (Beta)
1.70
Dividend Yield
N/A
Total Cash
1.68B
Total Cash/Share
7.88
Total Debt
576M
Total Debt/Equity
15.03
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.35%
Revenue
447M
ROE
N/A
Book Value
946M
P/B Ratio
44.84
Cash Flow
N/A
Earnings
-6.19
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.13M
Current Ratio
4.63
Current Revenue Per Employee
111992.13
Dividends Per Share - Security
N/A
EBITDA
-1.09B
Float
N/A
Float - Current
N/A
Gross Income Margin
79.37
Revenue To Assets
-53.64
Shares Held By Institutions
41.6B
Shares Outstanding - Current
213M
Total Liabilities
1.42B
Total Volume MTD
N/A
Value
-1
Gain YTD
187.703
View a ticker or compare two or three
INSM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. INSM showed earnings on October 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
700 US Highway 202/206
Phone
+1 908 977-9900
Employees
912
Web
https://www.insmed.com